TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Clinical trial NCT02705755 · COMPLETED

Trial details

NCT number: NCT02705755
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neurogenic Orthostatic Hypotension Multiple System Atrophy (MSA) With Orthostatic Hypotension Pure Autonomic Failure Parkinson Disease Hypotension, Orthostatic Orthostatic Hypotension Pure Autonomic Failure With Orthostatic Hypotension Parkinson Disease With Orthostatic Hypotension

Start date: 2017-09-09
Primary completion: 2018-07-24
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.